Subscribe
shutterstock_492675739_mdart10
MDart10 / Shutterstock.com
10 May 2022BiotechnologyAlex Baldwin

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

Canadian pharmaceutical company  GlycoBioSciences has sued cosmetics giant  L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More on this story

article
L’Oreal prevails in anti-aging treatment clash
12 January 2023   Dispute concerns two of the cosmetic giant’s best-selling brands | Arguments revolved around whether the French company could be sued in the US.
Americas
L’Oreal wins infringement suit over ‘indefinite’ patents
22 April 2021   L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.
Americas
Allergan sues cosmetics companies for trademark infringement
7 April 2017   Allergan has filed a complaint against cosmetics companies Dermavita and Dima and PR company KBC Media for trademark infringement and false advertising.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB